PDGFRA and glioma: The amplification and activation of EGFR, platelet derived growth factor receptor α (PDGFRα), and mesenchymal-epithelial transition factor (MET) promote the proliferation and invasion of glioma cells and are correlated with recurrence and therapeutic resistance (21–24).